Merck & Co., US58933Y1055

Merck stock climbs 2.0 percent ahead of the open

Published on 09/25/2026 at 07:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Merck stock had risen 2.0 percent to USD 150.98, with a session high of USD 151.10. The next quarterly results are scheduled for October 29, 2026.

Photorealistic wide-angle view of a modern oncology research laboratory. A scientist in white lab coat examines cancer cell slides under a fluorescence microscope. Amber glass vials with pharmaceutical compounds line the stainless steel bench. Biosafety c
Merck US58933Y1055 Onkologie-Labor: Wissenschaftler am Mikroskop analysiert Krebszellen, mehrere Wirkstoff-Vials stehen auf der Werkbank, Illustration mit AI erstellt.

Merck stock closed at USD 150.98 on the New York Stock Exchange on September 24, 2026, up 2.0 percent from the previous close. The gain exceeded the Dow Jones Industrial Average, which fell 0.3 percent to 51,349.98 in the same session.

September 24, 2026 in numbers

Merck and Co., Inc. (ISIN US58933Y1055) reached a session high of USD 151.10 after opening at USD 148.01. Trading volume had reached 180,896 shares at 4:28 p.m. Eastern time, while the stock remained 3.93 percent below its 52-week high of USD 156.91.

The Dow Jones Industrial Average fell 161.61 points, or 0.3 percent, to 51,349.98 on September 24, 2026. The Nasdaq Composite moved up 3.34 points, or less than 0.1 percent, to 26,939.37, while the S&P 500 slipped 1.90 points to 7,704.13.

October 29, 2026 results date

The next quarterly results are scheduled for October 29, 2026, according to finanzen.ch. The September 24 session also followed a broader market pause, with the Dow falling 0.3 percent and the Nasdaq Composite rising less than 0.1 percent.

Disclaimer...

en | US58933Y1055 | MERCK & CO. | boerse | 70181477 | bgmi